Apotheek De Geyter: what changed
What changed
Apotheek De Geyter
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€73,700
2024 · €66,479+€7,221
Equity
€137,221
2024 · €134,521+€2,700
Cash
€23,379
2024 · €17,986+€5,393
Balance sheet total
€432,080
2024 · €436,785-€4,705
Largest movements
Assets
- Stocks and contracts +€28,839
up €28,839 (+16.7%), from €172,237 to €201,076
- Receivables within one year -€25,315
down €25,315 (-12.5%), from €202,674 to €177,359
of which Other amounts receivable: -€39,983
- Tangible fixed assets -€14,726
down €14,726 (-42.7%), from €34,515 to €19,789
of which Other tangible fixed assets: -€16,291
- Cash +€5,393
up €5,393 (+30.0%), from €17,986 to €23,379
mainly Net result for the year (+€73,700) and Receivables within one year (+€25,315)
Equity and liabilities
- Profit (loss) carried forward +€22,143
up €22,143, from -€22,143 to €0
- Current portion of long-term debt -€22,033
down €22,033 (-72.6%), from €30,356 to €8,323
- Other debts +€20,996
up €20,996 (+29.4%), from €71,312 to €92,307
- Reserves -€19,443
down €19,443 (-20.5%), from €94,664 to €75,221
of which Distributable reserves: -€19,443
- Trade debts +€14,584
up €14,584 (+38.4%), from €37,964 to €52,548
Income statement
- Gross operating margin -€46,553
down €46,553 (-24.4%), from €191,042 to €144,490
- Staff costs -€29,815
down €29,815 (-40.9%), from €72,946 to €43,131
- Depreciation -€24,387
down €24,387 (-55.8%), from €43,719 to €19,331
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€66,479
Gross operating margin
-€46,553
Staff costs
+€29,815
Depreciation
+€24,387
Other operating charges
-€123
Financial income
-€70
Financial charges
+€1,263
Taxes
-€1,499
Result 2025
€73,700
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€117,723
Investment
-€4,605
Financing
-€107,725
Cash 2024
€17,986
From operations (derived)
+€117,723
Net result for the year
+€73,700
Depreciation
+€19,331
Stocks and contracts
-€28,839
Receivables within one year
+€25,315
Deferred charges and accrued income
-€1,104
Trade debts
+€14,584
Tax, wage and social debts
-€5,874
Advances received
-€151
Other debts
+€20,996
Accrued charges and deferred income
-€237
Investment (derived)
-€4,605
Investment in fixed assets (net)
-€4,605
Financing
-€107,725
Debts after one year
-€6,448
Current portion of long-term debt
-€22,033
Short-term financial debts
-€8,244
Contributions, distributions and other
-€71,000
Cash 2025
€23,379
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €436,785 | €432,080 | -€4,705 | -1.1% |
| Fixed assets | 21/28 | €39,515 | €24,789 | -€14,726 | -37.3% |
| Tangible fixed assets | 22/27 | €34,515 | €19,789 | -€14,726 | -42.7% |
| Plant, machinery and equipment | 23 | €17,066 | €18,630 | +€1,564 | +9.2% |
| Other tangible fixed assets | 26 | €17,450 | €1,159 | -€16,291 | -93.4% |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €397,269 | €407,290 | +€10,021 | +2.5% |
| Stocks and contracts in progress | 3 | €172,237 | €201,076 | +€28,839 | +16.7% |
| Stocks | 30/36 | €172,237 | €201,076 | +€28,839 | +16.7% |
| Amounts receivable within one year | 40/41 | €202,674 | €177,359 | -€25,315 | -12.5% |
| Trade receivables | 40 | €44,426 | €59,094 | +€14,668 | +33.0% |
| Other amounts receivable | 41 | €158,248 | €118,265 | -€39,983 | -25.3% |
| Cash at bank and in hand | 54/58 | €17,986 | €23,379 | +€5,393 | +30.0% |
| Deferred charges and accrued income | 490/1 | €4,372 | €5,477 | +€1,104 | +25.3% |
| Total equity and liabilities | 10/49 | €436,785 | €432,080 | -€4,705 | -1.1% |
| Equity | 10/15 | €134,521 | €137,221 | +€2,700 | +2.0% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €94,664 | €75,221 | -€19,443 | -20.5% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €88,464 | €69,021 | -€19,443 | -22.0% |
| Profit (loss) carried forward | 14 | -€22,143 | €0 | +€22,143 | |
| Amounts payable | 17/49 | €302,264 | €294,858 | -€7,406 | -2.5% |
| Amounts payable after more than one year | 17 | €110,959 | €104,511 | -€6,448 | -5.8% |
| Financial debts | 170/4 | €10,959 | €4,511 | -€6,448 | -58.8% |
| Trade debts | 175 | €100,000 | €100,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €189,372 | €188,651 | -€721 | -0.4% |
| Current portion of amounts payable after more than one year | 42 | €30,356 | €8,323 | -€22,033 | -72.6% |
| Financial debts | 43 | €37,665 | €29,421 | -€8,244 | -21.9% |
| Credit institutions | 430/8 | €37,665 | €29,421 | -€8,244 | -21.9% |
| Trade debts | 44 | €37,964 | €52,548 | +€14,584 | +38.4% |
| Suppliers | 440/4 | €37,964 | €52,548 | +€14,584 | +38.4% |
| Advances received on contracts in progress | 46 | €151 | €0 | -€151 | -100% |
| Taxes, remuneration and social security | 45 | €11,925 | €6,052 | -€5,874 | -49.3% |
| Taxes | 450/3 | €457 | €460 | +€3 | +0.7% |
| Remuneration and social security | 454/9 | €11,468 | €5,592 | -€5,877 | -51.2% |
| Other amounts payable | 47/48 | €71,312 | €92,307 | +€20,996 | +29.4% |
| Accrued charges and deferred income | 492/3 | €1,933 | €1,697 | -€237 | -12.2% |
| Remuneration, social security and pensions | 62 | €72,946 | €43,131 | -€29,815 | -40.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €43,719 | €19,331 | -€24,387 | -55.8% |
| Other operating charges | 640/8 | €5,628 | €5,751 | +€123 | +2.2% |
| Gross operating margin | 9900 | €191,042 | €144,490 | -€46,553 | -24.4% |
| Operating profit (loss) | 9901 | €68,750 | €76,277 | +€7,527 | +10.9% |
| Financial income | 75/76B | €5,080 | €5,010 | -€70 | -1.4% |
| Recurring financial income | 75 | €5,080 | €5,010 | -€70 | -1.4% |
| Financial charges | 65/66B | €6,915 | €5,652 | -€1,263 | -18.3% |
| Recurring financial charges | 65 | €6,915 | €5,652 | -€1,263 | -18.3% |
| Profit (loss) for the period before taxes | 9903 | €66,915 | €75,635 | +€8,720 | +13.0% |
| Income taxes | 67/77 | €436 | €1,934 | +€1,499 | +344% |
| Profit (loss) for the period | 9904 | €66,479 | €73,700 | +€7,221 | +10.9% |
| Profit (loss) for the period to be appropriated | 9905 | €66,479 | €73,700 | +€7,221 | +10.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.